Analyst Upgrades – CAH – Cardinal Health (NYSE:CAH) Stock Gets Upgraded By Argus from Hold to Buy

ME Staff
-
0

Analyst Ratings For CAH – Cardinal Health (NYSE:CAH)

Today, CAH – Cardinal Health (NYSE:CAH) stock received an upgrade by Argus from Hold to Buy with a price target of $85.00.

Some recent analyst ratings include

  • 4/2/2018-Argus Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 3/8/2018-Barclays initiated coverage with a Equal Weight rating.
  • 2/27/2018-Bank of America initiated coverage with a Underperform rating.
  • 1/17/2018-Robert W. Baird Reiterated Rating of Hold.

Dividend information for CAH – Cardinal Health (NYSE:CAH)

CAH – Cardinal Health (NYSE:CAH) pays an annual dividend of $1.85 with a yield of 2.91% and an average dividend growth of 12.20% based on a 3 Year Average..

Dividend History for CAH – Cardinal Health (NYSE:CAH)

  • On 2/7/2018 CAH – Cardinal Health announced a quarterly dividend of $0.46 2.95% with an ex dividend date of 3/29/2018 which will be payable on 4/15/2018.
  • On 11/8/2017 CAH – Cardinal Health announced a quarterly dividend of $0.46 3.05% with an ex dividend date of 12/29/2017 which will be payable on 1/15/2018.
  • On 8/9/2017 CAH – Cardinal Health announced a quarterly dividend of $0.46 2.75% with an ex dividend date of 9/29/2017 which will be payable on 10/15/2017.
  • On 5/3/2017 CAH – Cardinal Health announced a quarterly dividend of $0.46 2.54% with an ex dividend date of 6/29/2017 which will be payable on 7/15/2017.
  • On 2/2/2017 CAH – Cardinal Health announced a quarterly dividend of $0.45 2.4% with an ex dividend date of 3/30/2017 which will be payable on 4/15/2017.
  • On 11/3/2016 CAH – Cardinal Health announced a quarterly dividend of $0.45 2.76% with an ex dividend date of 12/29/2016 which will be payable on 1/15/2017.
  • On 8/8/2016 CAH – Cardinal Health announced a quarterly dividend of $0.45 2.14% with an ex dividend date of 9/29/2016 which will be payable on 10/15/2016.

Recent Insider Trading Activity For CAH – Cardinal Health (NYSE:CAH)
CAH – Cardinal Health (NYSE:CAH) has insider ownership of 0.97% and institutional ownership of 89.98%.

  • On 2/20/2018 Jon L Giacomin, CEO, sold 7,995 with an average share price of $68.78 per share and the total transaction amounting to $549,896.10.
  • On 2/14/2018 Patricia Morrison, Insider, sold 28,532 with an average share price of $66.30 per share and the total transaction amounting to $1,891,671.60.
  • On 1/22/2018 Michael C Kaufmann, CEO, sold 18,586 with an average share price of $73.90 per share and the total transaction amounting to $1,373,505.40.
  • On 5/12/2017 Jon L Giacomin, CEO of Cardinal Health’s pharmaceutical segment, sold 23,270 with an average share price of $72.87 per share and the total transaction amounting to $1,695,684.90.
  • On 2/10/2017 George S Barrett, Chairman, sold 217,994 with an average share price of $77.23 per share and the total transaction amounting to $16,835,676.62.
  • On 11/10/2016 George S Barrett, Chairman, sold 217,995 with an average share price of $71.29 per share and the total transaction amounting to $15,540,863.55.
  • On 8/18/2016 Patricia Morrison, Insider, sold 43,959 with an average share price of $82.50 per share and the total transaction amounting to $3,626,617.50.

Recent Trading Activity for CAH – Cardinal Health (NYSE:CAH)
Shares of CAH – Cardinal Health closed the previous trading session at with 64.43499755859375 shares trading hands.